Wake Forest School of medicine researchers together with the National Institute on Drug Abuse are striving to combat the country’s opioid crisis and could possibly have developed an analgesic that is harmless and non-addictive in an animal model.
Adults with attention-deficit/hyperactivity disorder (ADHD) are simultaneously consuming stimulants and opioids, warranting a necessity for research into the merits and demerits of prolonged joint-administration of these drugs.
In a bid to better handle the prescription and workflow processes of a practice, the orthopedic surgeons at Affiliated Oral and Maxillofacial Surgeons of Maryland have come up with a fresh mobile medication management application which allows each doctor to write about 30 prescriptions per day for controlled substances, including opioids for pain management.
The US government and federal agencies are taking many initiatives to stop the epidemic. However, Facebook recently received critical warnings due to its negative role in opioid addiction. The social media giant reportedly announced that users who attempt to purchase opioids or locate addiction treatments will be redirected to federal crisis helpline information.
Scott Gottlieb, FDA Commissioner is looking for help from Facebook and Twitter to slow down the unauthorized opioid sales in the US. Gottlieb invited the two social media giants, among others, to participate in the FDA Online Opioid Summit which is set for June 27.
According to the FDA, if the antidote drugs are used on a patient, they could suffer from “allergic reactions, local irritation” and a wide number of cardiovascular issues, including restriction of blood supply to tissues. The FDA stated that there has not yet been any reports of patient harm from Naloxone.
In November, FDA’s device center will select which app is welcomed into the program, and the selected will have amplified interactions with FDA during the progress of their products. FDA will grant the advanced device nomination to products that meet the permitted criteria without requiring a separate application.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.